SK144293A3 - Orally active antiviral compounds - Google Patents
Orally active antiviral compounds Download PDFInfo
- Publication number
- SK144293A3 SK144293A3 SK1442-93A SK144293A SK144293A3 SK 144293 A3 SK144293 A3 SK 144293A3 SK 144293 A SK144293 A SK 144293A SK 144293 A3 SK144293 A3 SK 144293A3
- Authority
- SK
- Slovakia
- Prior art keywords
- compound
- compounds
- alkyl
- formula
- compound according
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
- C07C69/92—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/28—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/42—Singly bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Dental Preparations (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71745191A | 1991-06-19 | 1991-06-19 | |
| PCT/US1992/004961 WO1992022520A1 (en) | 1991-06-19 | 1992-06-17 | Orally active antiviral compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK144293A3 true SK144293A3 (en) | 1994-06-08 |
Family
ID=24882086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1442-93A SK144293A3 (en) | 1991-06-19 | 1992-06-17 | Orally active antiviral compounds |
Country Status (23)
| Country | Link |
|---|---|
| US (4) | US5559133A (de) |
| EP (2) | EP0590026B1 (de) |
| JP (1) | JP2625258B2 (de) |
| KR (1) | KR960004887B1 (de) |
| AT (1) | ATE182874T1 (de) |
| AU (1) | AU674657B2 (de) |
| CA (1) | CA2111854C (de) |
| CZ (1) | CZ279793A3 (de) |
| DE (1) | DE69229733T2 (de) |
| ES (1) | ES2134808T3 (de) |
| FI (1) | FI935690A (de) |
| IE (1) | IE921971A1 (de) |
| IL (1) | IL102241A0 (de) |
| MX (1) | MX9203068A (de) |
| MY (1) | MY107993A (de) |
| NZ (1) | NZ243180A (de) |
| OA (1) | OA09828A (de) |
| PL (1) | PL169699B1 (de) |
| SK (1) | SK144293A3 (de) |
| TW (1) | TW260658B (de) |
| WO (1) | WO1992022520A1 (de) |
| YU (1) | YU63392A (de) |
| ZA (1) | ZA924445B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| YU63392A (sh) * | 1991-06-19 | 1994-11-15 | Schering Corporation | Bis(oksi) jedinjenja i postupak za njihovo dobijanje |
| JPH08507062A (ja) * | 1993-02-26 | 1996-07-30 | シェリング・コーポレーション | ヒトにおけるエンテロウイルス感染症の選択的処置のための２−クロロ−１−［［４−［（２，６−ジクロロフェノキシ）メチル］フェニル］メトキシ］−４−メトキシベンゼンの使用 |
| US5958983A (en) * | 1997-04-10 | 1999-09-28 | Pharmacia & Upjohn Company | Polyaromatic antiviral compositions |
| AU6462500A (en) * | 1999-07-29 | 2001-02-19 | Patrick T. Prendergast | Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2418571A1 (de) * | 1973-04-18 | 1974-11-14 | Ciba Geigy Ag | Phenyl-aralkyl-aether, diphenyle und benzophenone, verfahren zu ihrer herstellung und ihre verwendung |
| JPS509785A (de) * | 1973-05-31 | 1975-01-31 | ||
| JPS5922697B2 (ja) * | 1976-01-13 | 1984-05-28 | エーザイ株式会社 | ビス−（メタ−アミジノフエノキシ）−化合物 |
| JPS5651423A (en) | 1979-09-13 | 1981-05-09 | Wellcome Found | Antiviral agent |
| EP0099933B1 (de) * | 1982-01-29 | 1986-04-02 | Toray Industries, Inc. | Verfahren zur herstellung von alpha,omega-bis(2-chlorophenoxy)-alkan-4,4'-dikarbonsäure oder deren niedrigalkylester |
| US4851423A (en) | 1986-12-10 | 1989-07-25 | Schering Corporation | Pharmaceutically active compounds |
| JPH0621083B2 (ja) * | 1986-12-22 | 1994-03-23 | 株式会社三光開発科学研究所 | ジ（アリ−ルオキシ）アルカンの製造方法 |
| US4891449A (en) * | 1988-06-30 | 1990-01-02 | Great Lakes Chemical Corporation | Halogenated unsymmetrical higher alkyl phenoxy alkanes |
| AU6062590A (en) * | 1989-07-07 | 1991-02-06 | Schering Corporation | Pharmaceutically active compounds |
| YU63392A (sh) * | 1991-06-19 | 1994-11-15 | Schering Corporation | Bis(oksi) jedinjenja i postupak za njihovo dobijanje |
-
1992
- 1992-06-17 YU YU63392A patent/YU63392A/sh unknown
- 1992-06-17 JP JP5501035A patent/JP2625258B2/ja not_active Expired - Lifetime
- 1992-06-17 AT AT92913416T patent/ATE182874T1/de active
- 1992-06-17 ZA ZA924445A patent/ZA924445B/xx unknown
- 1992-06-17 SK SK1442-93A patent/SK144293A3/sk unknown
- 1992-06-17 TW TW081104731A patent/TW260658B/zh active
- 1992-06-17 PL PL92301825A patent/PL169699B1/pl unknown
- 1992-06-17 CZ CS932797A patent/CZ279793A3/cs unknown
- 1992-06-17 EP EP92913416A patent/EP0590026B1/de not_active Expired - Lifetime
- 1992-06-17 EP EP92305551A patent/EP0519702A1/de active Pending
- 1992-06-17 AU AU22213/92A patent/AU674657B2/en not_active Ceased
- 1992-06-17 IL IL102241A patent/IL102241A0/xx unknown
- 1992-06-17 DE DE69229733T patent/DE69229733T2/de not_active Expired - Lifetime
- 1992-06-17 WO PCT/US1992/004961 patent/WO1992022520A1/en active IP Right Grant
- 1992-06-17 CA CA002111854A patent/CA2111854C/en not_active Expired - Lifetime
- 1992-06-17 NZ NZ243180A patent/NZ243180A/en unknown
- 1992-06-17 MY MYPI92001031A patent/MY107993A/en unknown
- 1992-06-17 US US08/167,812 patent/US5559133A/en not_active Expired - Lifetime
- 1992-06-17 ES ES92913416T patent/ES2134808T3/es not_active Expired - Lifetime
- 1992-06-17 KR KR1019930703932A patent/KR960004887B1/ko not_active IP Right Cessation
- 1992-06-19 MX MX9203068A patent/MX9203068A/es active IP Right Grant
- 1992-07-01 IE IE197192A patent/IE921971A1/en not_active Application Discontinuation
-
1993
- 1993-03-26 US US08/039,532 patent/US5350772A/en not_active Expired - Lifetime
- 1993-12-17 OA OA60450A patent/OA09828A/en unknown
- 1993-12-17 FI FI935690A patent/FI935690A/fi not_active Application Discontinuation
-
1994
- 1994-08-08 US US08/287,325 patent/US5449782A/en not_active Expired - Lifetime
-
1995
- 1995-05-19 US US08/444,583 patent/US5618849A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| YU63392A (sh) | 1994-11-15 |
| WO1992022520A1 (en) | 1992-12-23 |
| FI935690A0 (fi) | 1993-12-17 |
| MY107993A (en) | 1996-07-15 |
| EP0519702A1 (de) | 1992-12-23 |
| AU674657B2 (en) | 1997-01-09 |
| OA09828A (en) | 1994-04-15 |
| US5449782A (en) | 1995-09-12 |
| CA2111854A1 (en) | 1992-12-23 |
| TW260658B (de) | 1995-10-21 |
| ZA924445B (en) | 1993-02-24 |
| US5559133A (en) | 1996-09-24 |
| DE69229733T2 (de) | 1999-12-02 |
| KR960004887B1 (ko) | 1996-04-16 |
| EP0590026B1 (de) | 1999-08-04 |
| CA2111854C (en) | 2001-01-09 |
| MX9203068A (es) | 1993-07-01 |
| US5618849A (en) | 1997-04-08 |
| DE69229733D1 (de) | 1999-09-09 |
| IE921971A1 (en) | 1992-12-30 |
| PL169699B1 (en) | 1996-08-30 |
| ES2134808T3 (es) | 1999-10-16 |
| JPH06503839A (ja) | 1994-04-28 |
| ATE182874T1 (de) | 1999-08-15 |
| AU2221392A (en) | 1993-01-12 |
| US5350772A (en) | 1994-09-27 |
| FI935690A (fi) | 1993-12-17 |
| JP2625258B2 (ja) | 1997-07-02 |
| IL102241A0 (en) | 1993-01-14 |
| CZ279793A3 (en) | 1994-05-18 |
| EP0590026A1 (de) | 1994-04-06 |
| NZ243180A (en) | 1995-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU85856A1 (fr) | Composes de phenethanolamine | |
| EP0181793A1 (de) | Piperidinderivate, Verfahren zu deren Herstellung und deren therapeutische Anwendung | |
| WO1993004035A1 (de) | Neue 3,5-di-tert.butyl-4-hydroxyphenyl-derivate, verfahren zu ihrer herstellung und arzneimittel | |
| DE10046029A1 (de) | Indazole | |
| FR2567510A1 (fr) | Composes d'aminophenol et compositions pharmaceutiques les contenant | |
| AU2002331145B2 (en) | Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders | |
| KR100281867B1 (ko) | 3-(비스-치환페닐메틸렌)옥신돌유도체 | |
| WO2019105234A1 (zh) | 芳香族化合物及其药物组合物和用途 | |
| DK158460B (da) | Analogifremgangsmaade til fremstilling af substituerede oxocarboxylsyrer | |
| SK144293A3 (en) | Orally active antiviral compounds | |
| ITMI20111463A1 (it) | 1,4-diaril-2-azetidinoni ad attivita' antitumorale | |
| DE3317529A1 (de) | Aletheinderivate | |
| WO2006088080A1 (ja) | シクロヘプタ［ｂ］ピリジン－３－カルボニルグアニジン誘導体およびそれを含有する医薬品 | |
| JPH01104064A (ja) | 塩基性に置換されたベンゾフランカルボン酸アミド、この化合物の製法及びこれを含有する医薬 | |
| DD157796A5 (de) | Verfahren zur herstellung neuer derivate des 2-amino-aethanols | |
| DE19836406A1 (de) | N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung | |
| JPS63227582A (ja) | 新規２−（２，３−ジヒドロ−２−オキソ−３−ベンゾフラニル）酢酸誘導体その製造法およびそれを含有する薬学的組成物 | |
| DE3907512C2 (de) | Neue Aryloxy-alkylamine, deren Herstellung und diese enthaltende Arzneimittel | |
| SI9400221A (en) | Orally active antipicornaviral compounds | |
| DE2339862A1 (de) | Neue substituierte phenylessigsaeureester und verfahren zu ihrer herstellung | |
| NZ270131A (en) | Orally active antiviral aromatic ether compounds | |
| HRP920365A2 (en) | Bis(oxy) compounds and process for their preparation | |
| JPH0358985A (ja) | ホモピペラジン誘導体及びこれを含有する脳保護剤 | |
| SI9200271A (sl) | Substituirani derivati karboksilnih kislin | |
| JPS63313750A (ja) | ２−（２−フルオロ−４−ビフエニリル）プロピオン酸エステル及びそれを有効成分とする抗炎症剤 |